Vitamin/Mineral Absorption From Two Different Supplements

NCT ID: NCT05336994

Last Updated: 2022-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-29

Study Completion Date

2022-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this project is to evaluate the postprandial serum and plasma vitamin and mineral levels in healthy adult men and women between 18 and 32 years of age, following a single intake of a multivitamin and mineral supplement processed in two different ways.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Serum or plasma levels of five vitamins and four minerals will be measured at baseline, and 1, 2, 4, and 6 hours after the intake of a multivitamin/mineral supplement processed by two different methods. The two methods involve using either conventional isolated vitamins and minerals blended together to provide approximately 100% of the Daily Value, or using the same amount of vitamins and minerals that have first been processing into liposomal forms before blending.

Participants are required to come for two study visits which are 5 to 7 days apart. Health screening will also be done at Study Visit 1. The order of supplement assignment will be randomized, performed in a double-blind manner.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Nutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will be randomly assigned to receive either supplement A or supplement B during the first visit. Five to seven days later, participants will receive the other supplement.
Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multivitamin/mineral supplement A to B

Participants will be randomly assigned to receive Supplement A and after 5-7 days of follow-up, they will receive Supplement B.

Group Type EXPERIMENTAL

Multivitamin/mineral supplement A

Intervention Type DIETARY_SUPPLEMENT

Oral administration of Supplement A

Multivitamin/mineral supplement B

Intervention Type DIETARY_SUPPLEMENT

Oral administration of Supplement B

Multivitamin/mineral supplement B to A

Participants will be randomly assigned to receive Supplement B and after 5-7 days of follow-up, they will receive Supplement A.

Group Type EXPERIMENTAL

Multivitamin/mineral supplement A

Intervention Type DIETARY_SUPPLEMENT

Oral administration of Supplement A

Multivitamin/mineral supplement B

Intervention Type DIETARY_SUPPLEMENT

Oral administration of Supplement B

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multivitamin/mineral supplement A

Oral administration of Supplement A

Intervention Type DIETARY_SUPPLEMENT

Multivitamin/mineral supplement B

Oral administration of Supplement B

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy males and females 18-32 years of age
* BMI 18.5-32 kg/m2
* Free from disease
* Normal blood levels in the comprehensive metabolic panel, or values slightly out of range as approved by the study physician
* Normal blood pressure (individuals whose average blood pressure is greater than 140/90 will be excluded from the study)
* Suitable vein structure and access for successful placement of an indwelling catheter, as determined by our nurse phlebotomist

Exclusion Criteria

* Alcohol consumption \> 3 drinks/week (i.e., 1 bottle of beer, 1 glass of wine, and 1 shot of hard liquor)
* Smoking
* Vaping or using cannabis in any form
* Using multivitamin/mineral supplements in the past two months
* Currently taking supplements including botanical supplements, probiotics or fiber
* Fruit consumption ≥ 2 cups/day
* Vegetable consumption ≥ 3 cups/day
* Coffee/tea ≥ 3 cups/day
* Chronic/routine high-intensity exercise
* Any chronic health conditions
* Self-reported malabsorption
* Currently taking prescription drugs
* Indications of substance or alcohol abuse within the last 3 years
* Unable to consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

32 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert M. Hackman, PhD

Role: PRINCIPAL_INVESTIGATOR

Research Nutritionist

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ragle Human Nutrition Research Center

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1692409

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of AN777 in Elderly Subjects
NCT00798291 COMPLETED PHASE2/PHASE3